Study Finds COVID-19 mRNA Vaccine Sparks Immune Response To Fight Cancer (UF Health)
A team led by UF researchers Elias Sayour and Christiano Marconi discovered that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting an immunotherapy treatment for advanced forms of lung cancer or melanoma lived significantly longer than those who didn’t get the vaccine.
Scientists Blaze New Path to Fighting Viral Diseases (UF Scripps)
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by UF researchers has identified a potential new drug against the virus that causes COVID-19.
Artificial Intelligence Can Help Predict the Next Pandemic
UF researchers have published an algorithm capable of predicting which COVID-19 variant in circulation today is most likely to become dominant in the next three months.
Did COVID-19 Prediction Formulas Miss Something? New Study Suggests Yes
UF researchers suggest that prediction models used by decision makers in attempting to control the spread of COVID-19 were incomplete, showing the need for more accurate forecasting.
How To Avoid Winter Viruses: UF EPI Expert Talks RSV, Flu and COVID-19
UF researcher Frederick Southwick discusses the increased prevalence of respiratory viruses—influenza, COVID-19, and RSV—during the winter in Florida and provides tips on how to avoid them.
New Study Shows Shoplifting Is Up 93% Since Before the COVID-19 Pandemic
UF startup LPRC conducted a study to examine how theft and violence have evolved since before COVID-19. The study revealed a significant increase in both the average number of shoplifting incidents and the dollars lost due to shoplifting.
Patients With Diabetes Are As Satisfied With Telehealth As With In-Person Care
UF researcher finds that people with diabetes who participate in telehealth doctor visits report the same levels of quality of care, trust in the healthcare system, and patient-centered communication as those who receive care through in-person visits.
National Cade Prize for Innovation Names 21 Finalists
Judges for 2023’s National Cade Prize for Innovation named this year’s 21 Fibonacci Finalists. Finalists will compete to win $10,000 in their respective category group—Agriculture and Environmental, Healthcare/Biomedical, IT/Tech, Energy, and Wildcard. One of the five category winners will be selected as the Inventivity™ Grand Prize winner and take home an additional $50,000 prize. Two UF startups — Lactovid and Analyz — are listed among the Fibonacci Finalists.
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post COVID Syndrome’
Neobiosis, A UF Accelerate resident client, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for ViXome™, its drug for the treatment of ‘Post COVID Syndrome (AKA “Long Haul COVID Syndrome”).
UF researchers discover new way to inhibit virus that causes COVID-19
When the virus that causes COVID-19 enters the body, it hijacks cellular proteins and suppresses the human inflammatory response, allowing the virus to spread. University of Florida researchers have discovered a novel way in the lab to fight rapidly evolving strains of coronaviruses by breaking that cycle.